Lysulin secures 5th patent for diabetes management supplement The patent protects the formulation’s method it uses to prevent protein glycation.
Lysulin, Inc. recently announced they have secured patent approval for their flagship product Lysulin, a dietary supplement formulated for people with Type 2 diabetes and prediabetes.
“Although the formulation is very simple, it is covered by 5 issued patents. The main ingredients are lysine, zinc and vitamin C. All three ingredients have been individually shown to lower glucose and lysine stops protein glycation,” noted Dr. John Burd, founder & CEO of Lysulin, Inc.
The sponge effect
The company said their all-natural product provides a breakthrough approach for blood glucose management by preventing protein glycation, which is the cause of insulin resistance and type 2 diabetes.
Automotive Suspension Parts Market Dynamics and Forecast From 2020 – 2030 – KSU ksusentinel.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ksusentinel.com Daily Mail and Mail on Sunday newspapers.
- Emergence of electronic accounting that enables preserving tax module of financial data expands vistas in property tax services market. - Adoption of property tax services in different
Share this article
Share this article
ALBANY, N.Y., May 20, 2021 /PRNewswire/ Lyophilization refers to one of the most popular techniques employed today for the production of parenteral pharmaceutical products that do not maintain their stability in aqueous solution. The process is important for the protection of materials that need minimal moisture content (less than 1%) to achieve stability.
The popularity of lyophilized injectable drugs is increasing owing to their ability to remain stable at ambient temperatures. At the same time, they can be used following a simple rehydration process. As a result, this technique allows for avoiding various pipetting errors and helps in achieving streamlined and simplified workflows. On the back of all these advantages lyophilized injectable drugs, the global lyophilized injectable market is projected to gather lucrative avenues in the forthcoming years.
The swelling demand for non-carcinogenic sugar in the manufacturing of healthcare and food products will bring profitable growth for the isomaltulose market during the assessment period of 2020-2030 The